Indoco Remedies Total Revenues increased by 19.4% YoY to Rs 2586 mn (in line with our estimate of Rs 2588 mn) in Q3FY16 due to higher export formulations sale. Operating margins decreased by 300bps YoY to 16.7% (lower than our estimate of 18%) due to higher staff cost, R&D and overheads.